for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Noritsu Koki Co Ltd

7744.T

Latest Trade

1,519.00JPY

Change

10.00(+0.66%)

Volume

203,600

Today's Range

1,495.00

 - 

1,524.00

52 Week Range

1,427.00

 - 

2,535.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Gene Techno Science signs collaborative research agreement with chromocenter

July 30 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it signed collaborative research agreement with chromocenter Inc..Says two entities mainly cooperate on establishment of cell lines construction related the basic technologies .

Noritsu Koki to merge with wholly owned securities unit

July 20 (Reuters) - Noritsu Koki Co Ltd <7744.T>:Says it will merge with a Tokyo-based wholly owned unit, which is engaged in acquisition and possession of marketable securities, effective Sept. 1 .Says the unit will be dissolved after merger .

Noritsu Koki says change of president

May 22 (Reuters) - Noritsu Koki Co Ltd <7744.T>:Says it appoints Hirotsugu Nishimoto as chairman and Ryukichi Iwakiri as president, effective June 21 .

NanoCarrier says business and capital alliance with Gene Techno Science and Noritsu Koki

April 9(Reuters) - NanoCarrier Co Ltd <4571.T>:Says it plans business and capital alliance with Gene Techno Science Co Ltd <<<4584.T>>> and Noritsu Koki Co Ltd <<<7744.T>>>, regarding biopharmaceutical related business .Says NanoCarrier will acquire 500,000 shares (5.23 percent stake) of Gene Techno Science, for 1.22 billion yen .Says Noritsu Koki will acquire 1.5 million new shares (3.47 percent stake) of NanoCarrier, for 1.21 billion yen, through a private placement .Says shares acquisition date on April 27.

Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology

Nov 9 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it commenced the phase III clinical trial for biosimilars in ophthalmology, which is a joint work between the co and Senju Pharmaceutical Co Ltd .

Gene Techno Science sets up JV

June 7 (Reuters) - Gene Techno Science Co Ltd <4584.T>:* Says it established Sapporo-based JV with AIN HOLDINGS INC <9627.T>, North Pacific Bank,LTD.<8524.T> and a Sapporo-based investment limited liability partnership .* Says the JV is engaged in manufacture of regeneration medicine related product .* Says the co, AIN HOLDINGS INC, North Pacific Bank,LTD, investment limited liability partnership are both holding a 25 percent stake in the JV respectively.

Gene Techno Science announces change of chairman and president

Gene Techno Science Co Ltd <4584.T> :Says it appoints current president Masanari Kawaminami as new chairman, Masaharu Tani as new president, effective on April 1.

Gene Techno Science forms cooperation with ITOCHU CHEMICAL FRONTIER Corp

Gene Techno Science Co Ltd <4584.T>: Says the co to jointly develop biosimilars technology with ITOCHU CHEMICAL FRONTIER Corporation . Says the co will issue 199,800 shares to ITOCHU CHEMICAL FRONTIER Corporation for 301.9 million yen .Says effective March 27.

Gene Techno Science signs joint research and development contract with Juntendo University

Gene Techno Science Co Ltd <4584.T>: Says it signed a joint research and development contract for new immunosuppressive therapy with Juntendo University on Feb. 27 .Says contract period is from March 1, 2017 to Feb. 29, 2020.

Sanyo Homes to fully buy real estate unit of Noritsu Koki Co Ltd

Sanyo Homes Corp <1420.T>: Says it will buy 100 percent stake in real estate unit of Noritsu Koki Co Ltd <7744.T> on Jan. 5, 2017 . Says the acquisition price is not disclosed .Says the co plans to merge the newly acquired real estate unit on March 1, 2017.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up